- Release Date: 19/03/24 08:45
- Summary: First patients dosed in SPONTAN pivotal study
- Price Sensitive: Yes
- Download Document 156.8KB
- Forums
- ASX - By Stock
- Ann: First patients dosed in SPONTAN pivotal study
LTP
ltr pharma limited
Add to My Watchlist
1.67%
!
29.5¢

Ann: First patients dosed in SPONTAN pivotal study
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $33.58M |
Open | High | Low | Value | Volume |
29.5¢ | 29.5¢ | 29.5¢ | $9.154K | 31.02K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 16602 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 34553 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10344 | 0.290 |
5 | 115558 | 0.285 |
5 | 239066 | 0.280 |
3 | 80909 | 0.275 |
10 | 195657 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 34509 | 3 |
0.310 | 35264 | 4 |
0.315 | 11518 | 2 |
0.320 | 19762 | 2 |
0.325 | 79383 | 2 |
Last trade - 10.04am 30/06/2025 (20 minute delay) ? |
Featured News
LTP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online